If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs for those living with the chronic, unpredictabl ...
As you all know, Alnylam is pioneering an entirely new class of medicines to treat human disease. This generational technology leverages the mechanism of RNA interference, a natural process of gene ...
In 2013, WHO partnered with Ministries of Health and development partners in nine countries in Asia and the Pacific to ...
6don MSN
Healthy gut microbes in 6-week-old infants linked to lower risk of malaria during first year of life
In a small study in the Democratic Republic of Congo, 6-week-old infants with healthy gut microbiomes were less likely to contract malaria in their first year of life. While the study is preliminary, ...
The Seahawks will likely be shorthanded again in their secondary when they face the Jaguars on Sunday. Safety Julian Love (hamstring), cornerback Devon Witherspoon (knee) and cornerback Riq Woolen ...
Friday, June 26Even with a bright waxing Moon up most of the night, there are still plenty of targets for your telescope. One ...
"We're really excited... I'm one of five. He's one of four. Although we weren't originally planning it, it feels right," ...
Every Song That Topped the U.K. Chart for 8 or More Weeks, But Didn’t Make the Top 10 on the Hot 100
Add Yahoo as a preferred source to see more of our stories on Google. “Rein Me In” is one of just two singles to log 14 or more weeks at No. 1 in the U.K. without reaching the top 10 (or even the top ...
Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...
More stories by Kevin P.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results